Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin receptor antagonists – a patent review (2010 to August 2014)
Christoph Boss
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 12, pp. 1367-1381
Closed Access | Times Cited: 18

Showing 18 citing articles:

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 11, pp. 4648-4664
Closed Access | Times Cited: 76
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13
Strategies of Functional Foods Promote Sleep in Human Being
Yawen Zeng, Jia-Zhen Yang, Juan Du, et al.
Current Signal Transduction Therapy (2015) Vol. 9, Iss. 3, pp. 148-155
Open Access | Times Cited: 36
Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs
Anil Kumar, Priyanka Chanana, Supriti Choudhary
Pharmacological Reports (2015) Vol. 68, Iss. 2, pp. 231-242
Closed Access | Times Cited: 35
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 9, pp. 1884-1891
Closed Access | Times Cited: 31
Unmet needs of patients with narcolepsy: perspectives on emerging treatment options
Timothy Quinnell, Dariusz Woźniak
Nature and Science of Sleep (2015), pp. 51-51
Open Access | Times Cited: 22
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
J.A. Christopher, Sarah J. Aves, Jason Brown, et al.
MedChemComm (2015) Vol. 6, Iss. 5, pp. 947-955
Closed Access | Times Cited: 17
Orexin research: patent news from 2016
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1123-1133
Closed Access | Times Cited: 17
An overview of the orexinergic system in different animal species
Idris A. Azeez, Olumayowa O. Igado, James Olukayode Olopade
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1419-1444
Closed Access | Times Cited: 13
1,2-Benzisoxazole compounds: a patent review (2009 – 2014)
Yoshikazu Uto
Expert Opinion on Therapeutic Patents (2015) Vol. 25, Iss. 6, pp. 643-662
Closed Access | Times Cited: 14
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Functional characterization of an orexin neuropeptide in amphioxus reveals an ancient origin of orexin/orexin receptor system in chordate
Peng Wang, Meng Wang, Liping Zhang, et al.
Science China Life Sciences (2019) Vol. 62, Iss. 12, pp. 1655-1669
Closed Access | Times Cited: 9
Arcuate Nucleus Orexin-A Signaling Alleviates Cisplatin-Induced Nausea and Vomiting Through the Paraventricular Nucleus of the Hypothalamus in Rats
Feifei Guo, Shengli Gao, Xu Luo, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 6
Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Unacylated Ghrelin Regulates Glucose-Sensitive Neurons Activity and Glycolipid Metabolism via Orexin-A Neurons in the Lateral Hypothalamic Area
Manqing Su, Meixing Yan, Jiatong Yao, et al.
Hormone and Metabolic Research (2020) Vol. 52, Iss. 10, pp. 747-754
Closed Access | Times Cited: 1
Suvorexant (Belsomra), The First‐in‐Class Orexin Antagonist for Insomnia
Nadia Ahmad
(2015), pp. 223-242
Closed Access
Page 1

Scroll to top